L

L

LÓPEZ-CORRAL , L.

Last name: LÓPEZ-CORRAL

First name: L.

February 8, 2024 (v1)

Publication

Metadata-only

Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation

Caballero Velázquez, Teresa Calderón Cabrera, Cristina López-Corral, L.

This multicenter phase I trial was designed to evaluate the safety and efficacy of bortezomib (Bz) as part of both the conditioning regimen and the graft-versus-host disease (GvHD) prophylaxis. Patients received fludarabine, melphalan and Bz (days -9 and -2). GVHD prophylaxis consisted of Bz (days +1, +4, and +7), sirolimus (Siro) from day -5...

Uploaded on: February 11, 2024